Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vascular Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), Hepatocyte Growth Factor (HGF) in Patients With Acute Coronary Syndrome (ACS)

This study has been completed.
Sponsor:
Information provided by:
Institute of Cardiology, Warsaw, Poland
ClinicalTrials.gov Identifier:
NCT00844987
First received: February 13, 2009
Last updated: May 26, 2010
Last verified: May 2010